Phase 1 Study
The Phase 1 study of dutogliptin will evaluate safety, pharmacokinetics and pharmacodynamics in healthy volunteers after single and repeated parenteral application.
Status of Study
Approved; study and enrolment started in 05.2017 at the University Hospital of Vienna, Austria.
This study is designed with nine cohorts and will be an open-label, single center study evaluating the safety, pharmacokinetics and pharmacodynamics of parenterally administered dutogliptin in healthy volunteers.